Omeprazole and Serax drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omeprazole (omeprazole) and Serax (oxazepam). Common drug interactions include osteomyelitis among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Serax. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
What is Serax?
Serax has active ingredients of oxazepam. It is often used in stress and anxiety. eHealthMe is studying from 1,542 Serax users. Check the latest studies of Serax.
22 people who take Omeprazole and Serax together, and have interactions are studied.

What are the common drug interactions of Omeprazole and Serax, by gender? *:
female:
- Osteomyelitis (infection of bone)
- Nausea (feeling of having an urge to vomit)
- Thyroid cancer
- Wound infection bacterial
- Alopecia (absence of hair from areas of the body)
- Ankle fracture
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Diarrhoea
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Pneumonia
- Blood lactate dehydrogenase increased
- Confusional state
- Coronary artery stenosis (narrowing of coronary artery)
- Dehydration (dryness resulting from the removal of water)
- Disability
- Drug withdrawal convulsions
- Dyspnoea (difficult or laboured respiration)
- Fall
What are the common drug interactions of Omeprazole and Serax, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Coronary artery stenosis (narrowing of coronary artery)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Stomatitis (inflammation of mucous membrane of mouth)
60+:
- Febrile neutropenia (fever with reduced white blood cells)
- Pneumonia
- Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
- Bladder dysfunction
- Blood lactate dehydrogenase increased
- Confusional state
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Dehydration (dryness resulting from the removal of water)
- Disability
- Drug abuser
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 22.73%
- Pain: 4 people, 18.18%
- High Blood Pressure: 4 people, 18.18%
- Constipation: 3 people, 13.64%
- Osteoporosis (bones weak and more likely to break): 3 people, 13.64%
- Sleep Disorder: 3 people, 13.64%
- Hypotension (abnormally low blood pressure): 2 people, 9.09%
- Depression: 2 people, 9.09%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 9.09%
- Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and Serax?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Omeprazole (410,631 reports)
- Serax (1,542 reports)
Browse all drug interactions of Omeprazole and Serax:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Serax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Serax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on omeprazole and oxazepam (the active ingredients of Omeprazole and Serax, respectively), and Omeprazole and Serax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Keytruda and Idiopathic Pulmonary Fibrosis for Men aged 60+ - 10 seconds ago
- Keytruda and Usual Interstitial Pneumonitis for Men aged 60+ - 11 seconds ago
- Keytruda and Pulmonary Fibrosis for Men aged 60+ - 11 seconds ago
- Keytruda and Ipf for Men aged 60+ - 11 seconds ago
- Keytruda and Idiopathic Diffuse Interstitial Pulmonary Fibrosis for Men aged 60+ - 11 seconds ago
- Keytruda and Fibrosing Alveolitis for Men aged 60+ - 12 seconds ago
- Keytruda and Cryptogenic Fibrosing Alveolitis for Men aged 60+ - 12 seconds ago
- Keytruda and Cfa for Men aged 60+ - 12 seconds ago
- Keytruda and Uip for Men aged 60+ - 13 seconds ago
- Stools - Watery in Isoptin, how severe and when it was recovered? - 16 seconds ago